Prevention and control [of] methicillin-resistant Staphylococcus aureus (MRSA)

Hdl Handle:: http://hdl.handle.net/10147/317589
Title:: Prevention and control [of] methicillin-resistant Staphylococcus aureus (MRSA)
Authors:: National Clinical Effectiveness Committee (NCEC)
Citation:: National Clinical Effectiveness Committee (NCEC). Prevention and control [of] methicillin-resistant Staphylococcus aureus (MRSA). Dublin: NCEC; 2013 Dec 23 p
Publisher:: National Clinical Effectiveness Committee (NCEC)
Issue Date:: Dec-2013
URI:: http://hdl.handle.net/10147/317589
Item Type:: Report; Guideline
Language:: en
Description:: Staphylococcus aureus (S. aureus) commonly colonises the skin and nose. Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a strain of bacteria that has become resistant to the antibiotics commonly used to treat ordinary staphylococcal infections. In the right setting MRSA can cause severe and at times fatal infections such as bloodstream infection (BSI), infective endocarditis, pneumonia and skin and soft tissue infections (SSTI).
Keywords:: PATIENT SAFETY; QUALITY; CLINICAL GOVERNANCE; INFECTION CONTROL
Local subject classification:: AUDIT
Series/Report no.:: National Clinical Guideline; No. 2

Full metadata record

DC Field	Value	Language
dc.contributor.author	National Clinical Effectiveness Committee (NCEC)	en_GB
dc.date.accessioned	2014-05-28T15:42:26Z	-
dc.date.available	2014-05-28T15:42:26Z	-
dc.date.issued	2013-12	-
dc.identifier.citation	National Clinical Effectiveness Committee (NCEC). Prevention and control [of] methicillin-resistant Staphylococcus aureus (MRSA). Dublin: NCEC; 2013 Dec 23 p	en_GB
dc.identifier.uri	http://hdl.handle.net/10147/317589	-
dc.description	Staphylococcus aureus (S. aureus) commonly colonises the skin and nose. Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a strain of bacteria that has become resistant to the antibiotics commonly used to treat ordinary staphylococcal infections. In the right setting MRSA can cause severe and at times fatal infections such as bloodstream infection (BSI), infective endocarditis, pneumonia and skin and soft tissue infections (SSTI).	en_GB
dc.language.iso	en	en
dc.publisher	National Clinical Effectiveness Committee (NCEC)	en_GB
dc.relation.ispartofseries	National Clinical Guideline	en_GB
dc.relation.ispartofseries	No. 2	en_GB
dc.subject	PATIENT SAFETY	en_GB
dc.subject	QUALITY	en_GB
dc.subject	CLINICAL GOVERNANCE	en_GB
dc.subject	INFECTION CONTROL	en_GB
dc.subject.other	AUDIT	en_GB
dc.title	Prevention and control [of] methicillin-resistant Staphylococcus aureus (MRSA)	en_GB
dc.type	Report	en
dc.type	Guideline	en